Deinde presents its Instant-Calming Recovery Gel, featuring biotech-derived dihydrokaempferol (DHK) as the primary active ingredient. The cooling treatment demonstrates clinically proven efficacy in providing immediate relief while improving skin barrier function, per the company.
Novel Biotech Active: DHK from Prickly Pear
As Deinde reports, DHK (dihydrokaempferol) represents a breakthrough antioxidant naturally occurring in prickly pear cactus (Opuntia species), which demonstrates remarkable resilience in extreme environmental conditions. The biotech-derived version eliminates the sustainability challenges associated with traditional botanical extraction while maintaining the compound's therapeutic properties.
The ingredient's mechanism of action centers on immediate skin calming and soothing effects, delivering improved complexion evenness while enhancing skin resilience to environmental stressors over time.
Clinical applications include:
- post-procedure care,
- mitigation of active ingredient irritation (particularly retinol) and
- treatment of environmental damage including sunburn, windburn and xerosis.
Formulation Technology
The gel formulation additionally incorporates a multi-component active system beyond DHK:
- Polysaccharides: Sugar-based protective molecules to form a biomimetic barrier, shielding skin from environmental pollutants and particulate matter adhesion; and
- Biotech squalane: A skin-identical lipid that mimics kin's natural sebaceous composition, to optimizing moisture retention while providing lightweight sensory properties.
This combination reportedly supports Deinde's commitment to formulations with ≥ 94% bio-based content, aligning with industry sustainability targets.
Brand Portfolio Expansion
The launch represents Deinde's second biotech ingredient introduction, following the successful debut of patented biotech naringenin in 2023. This sequential development strategy demonstrates the brand's systematic approach to biotech ingredient innovation and sustainable formulation practices.
The Instant-Calming Recovery Gel will retail at US $42, positioning it competitively within the premium recovery treatment segment.
